LLY
910.17
+0.51%↑
UNH
569.99
-0.12%↓
NVO
116.46
-0.73%↓
JNJ
163.54
+0.57%↑
ABBV
188.97
+1.46%↑
LLY
910.17
+0.51%↑
UNH
569.99
-0.12%↓
NVO
116.46
-0.73%↓
JNJ
163.54
+0.57%↑
ABBV
188.97
+1.46%↑
LLY
910.17
+0.51%↑
UNH
569.99
-0.12%↓
NVO
116.46
-0.73%↓
JNJ
163.54
+0.57%↑
ABBV
188.97
+1.46%↑
LLY
910.17
+0.51%↑
UNH
569.99
-0.12%↓
NVO
116.46
-0.73%↓
JNJ
163.54
+0.57%↑
ABBV
188.97
+1.46%↑
LLY
910.17
+0.51%↑
UNH
569.99
-0.12%↓
NVO
116.46
-0.73%↓
JNJ
163.54
+0.57%↑
ABBV
188.97
+1.46%↑
Преглед
Промяна на цената на акция
24 ч
Текуща
Минимум
4.45
Максимум
4.77
Препоръки | Купи |
---|---|
12-месечна прогноза | +51.28 upside |
Следващи печалби | 7.11.2024 г. |
---|
Техническа оценка
By Trading Central
Увереност
Very Strong Bearish Evidence
N/A / 4.79 Подкрепа & съпротива
Adaptive Biotechnologies Corp Графика
Миналото представяне не гарантира бъдещи резултати.
Свързани новини
21.10.2024 г., 23:17 ч. UTC
Australian Consumer Confidence Highest Since Early 2023
DJ
Прочетени
21.10.2024 г., 20:42 ч. UTC
SAP 3Q Revenue, Profit Climb on AI Demand; Outlook Raised
DJ
Прочетени
21.10.2024 г., 22:57 ч. UTC
Ping An Insurance: Higher Income From Healthcare, Senior-Care Services Supported Results >2318.HK
DJ
Прочетени
21.10.2024 г., 22:57 ч. UTC
Ping An Insurance 9-Mos Rev CNY861.8B ; Up 8.7% on Year >2318.HK
DJ
Прочетени
21.10.2024 г., 22:57 ч. UTC
Ping An Insurance 9-Mos Net CNY119.2B; Up 36.1% on Year >2318.HK
DJ
Прочетени
21.10.2024 г., 22:10 ч. UTC
Webjet Looks Like an M&A Target, But Bids Unlikely Soon -- Market Talk
DJ
Прочетени
21.10.2024 г., 21:02 ч. UTC
Sanofi Deal Jitters Imperil Stock's Big Rebound -- Barrons.com
DJ
Прочетени
21.10.2024 г., 20:50 ч. UTC
Financial Services Roundup: Market Talk
DJ
Прочетени
21.10.2024 г., 20:50 ч. UTC
Basic Materials Roundup: Market Talk
DJ
Прочетени
21.10.2024 г., 20:50 ч. UTC
Tech, Media & Telecom Roundup: Market Talk
DJ
Прочетени
21.10.2024 г., 20:32 ч. UTC
Nucor: The Earnings of the Raw Materials Segment Are Expected to Increase in 4Q Compared to 3Q >NUE
DJ
Прочетени
21.10.2024 г., 20:31 ч. UTC
Nucor: Expect Consolidated Net Earnings Attributable to Nucor Stockholders in 4Q to Decrease >NUE
DJ
Прочетени
21.10.2024 г., 20:30 ч. UTC
Nucor 3Q Total Tons Shipped to Outside Customers Down 1% >NUE
DJ
Прочетени
21.10.2024 г., 20:30 ч. UTC
Nucor 3Q Steel Mills Total Shipments 5.72M Tons >NUE
DJ
Прочетени
21.10.2024 г., 20:30 ч. UTC
Nucor 3Q Average Sales Price Per Ton Down 15% >NUE
DJ
Прочетени
21.10.2024 г., 20:30 ч. UTC
Nucor 3Q EPS $1.05 >NUE
DJ
Прочетени
21.10.2024 г., 20:30 ч. UTC
Nucor 3Q Sales $7.44B >NUE
DJ
Прочетени
21.10.2024 г., 20:30 ч. UTC
Nucor 3Q Net $249.9M >NUE
DJ
Прочетени
21.10.2024 г., 20:20 ч. UTC
Glendon Capital Filing Mentions Reuters Article About Glendon Opposition to Verizon Deal
DJ
Прочетени
21.10.2024 г., 20:20 ч. UTC
Nvidia Reaches $3.5 Trillion Market Value. It's Right on Apple's Heels. -- Barrons.com
DJ
Прочетени
21.10.2024 г., 20:19 ч. UTC
Frontier Communications Shareholder Glendon Capital Will Continue to Engage in Talks With Relevant Parties About Sale to Verizon
DJ
Прочетени
21.10.2024 г., 20:15 ч. UTC
Global Commodities Roundup: Market Talk
DJ
Прочетени
21.10.2024 г., 20:14 ч. UTC
S&P 500, Dow Slip; Bond Yields Rise -- WSJ
DJ
Прочетени
21.10.2024 г., 20:10 ч. UTC
SAP Backs 2024 Cloud Revenue EUR17B-EUR17.3B >SAP
DJ
Прочетени
21.10.2024 г., 20:10 ч. UTC
SAP Raises 2024 Cloud and Software Revenue View to EUR29.5B-EUR29.8B >SAP
DJ
Прочетени
21.10.2024 г., 20:08 ч. UTC
SAP Sees Exiting 2024 at Headcount Slightly Ahead of Year-End 2023 >SAP
DJ
Прочетени
21.10.2024 г., 20:07 ч. UTC
SAP 3Q Cloud and Software Revenue EUR7.43B >SAP
DJ
Прочетени
21.10.2024 г., 20:07 ч. UTC
SAP 3Q Software Licenses Revenue EUR280M>SAP
DJ
Прочетени
21.10.2024 г., 20:06 ч. UTC
SAP 3Q Adj EPS EUR1.23 >SAP
DJ
Прочетени
21.10.2024 г., 20:06 ч. UTC
SAP 3Q EPS EUR1.25 >SAP
DJ
Прочетени
Сравнение с други в отрасъла
Ценова промяна
Adaptive Biotechnologies Corp Прогноза
Ценова цел
By TipRanks
12-месечна прогноза
Среден 7.08 USD 51.28%
Висок 10 USD
Нисък 5.5 USD
Според 7 анализатори от Wall Street, предложили 12-месечна ценова цел за Adaptive Biotechnologies Corp през последните три месеца.
Консенсусна оценка
By TipRanks
Купи
7 ratings
5
Купи
2
Задържане
0
Продай
Според 7 анализатори, дали борсови рейтинги на Adaptive Biotechnologies Corp през последните 3 месеца.
Техническа оценка
By Trading Central
Краткосрочен план
Very Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Средносрочен план
Neutral Evidence
The bullish and bearish events are balanced.
Дългосрочен план
Bullish Evidence
All events are bullish.
Финанси
$